Zobrazeno 1 - 10
of 13
pro vyhledávání: '"D. J. Clanton"'
Autor:
R Pedemonte, William Decker, V L Narayanan, Owen S. Weislow, J. B. McMahon, Robert W. Buckheit, R J Schultz, F W Wassmundt, R J Gulakowski, D. J. Clanton
Publikováno v:
Antimicrobial Agents and Chemotherapy. 37:754-760
A series of variously substituted diarylsulfones and related derivatives were found to prevent human immunodeficiency virus type 1 (HIV-1) replication and HIV-1-induced cell killing in vitro. One of the more potent derivatives, 2-nitrophenyl phenyl s
Autor:
C, Yoosook, V, Reutrakul, T, Santisuk, S, Chaichana, J M, Pezzuto, Y, Dong, D J, Clanton, R, Kiser, P, Staley
Publikováno v:
The Southeast Asian journal of tropical medicine and public health. 29(4)
Studies involving infectious, wild type HIV-1 must be performed under strict BSL-3 practice. We have employed a defective (deltaTat/Rev)MC99 and cloned 1A2 line, ie, mutated HIV-1 and Tat/Rev transfected cells to verify anti-HIV-1 activity in a BSL-2
Autor:
L Field, Catherine A. Schaeffer, R J Schultz, S Terpening, D. J. Clanton, P K Singh, D C Baker, Jim A. Turpin, R W Buckheit, J P Bader, M Bu, L Graham, William G. Rice
Publikováno v:
Antimicrobial agents and chemotherapy. 41(2)
The human immunodeficiency virus type 1 (HIV-1) nucleocapsid p7 protein contains two retrovirus-type zinc finger domains that are required for multiple phases of viral replication. Chelating residues (three Cys residues and one His residue) of the do
Autor:
D J, Clanton, R A, Moran, J B, McMahon, O S, Weislow, R W, Buckheit, M G, Hollingshead, V, Ciminale, B K, Felber, G N, Pavlakis, J P, Bader
Publikováno v:
Journal of acquired immune deficiency syndromes. 5(8)
Over 50 different commercially available sulfonic acid-containing dyes were analyzed for their ability to prevent HIV-1-induced cell killing and in inhibiting HIV-1 replication. Compounds of remarkably similar structure, but with differing patterns o
Autor:
Y, Ogiso, L, Gutierrez, L S, Wrathall, Y Y, Lu, D G, Blair, D J, Clanton, Y W, Hwang, T Y, Shih
Publikováno v:
Cell growthdifferentiation : the molecular biology journal of the American Association for Cancer Research. 1(5)
Site-directed mutagenesis of the conserved sequence motifs of p21 generated a group of mutant p21s defective in GTP binding. Some of these mutants were highly transforming, whereas others were transformation defective. Among the latter group, we foun
Publikováno v:
Journal of Investigative Medicine. 52:S140.7-S140
Autor:
John P. Bader, Robert W. Buckheit, R. A. Moran, George N. Pavlakis, Melinda G. Hollingshead, James B. McMahon, Owen S. Weislow, Vincenzo Ciminale, Barbara K. Felber, D. J. Clanton
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 5:771
Over 50 different commercially available sulfonic acid-containing dyes were analyzed for their ability to prevent HIV-1-induced cell killing and in inhibiting HIV-1 replication. Compounds of remarkably similar structure, but with differing patterns o
Autor:
Takaya Satoh, D J Clanton, Masao Kawakita, Yoshito Kaziro, Seisuke Hattori, Shun Nakamura, Thomas Y. Shih
Publikováno v:
Molecular and Cellular Biology. 7:1999-2002
The neutralizing monoclonal antibody Y13-259 severely hampers the nucleotide exchange reaction between p21-bound and exogenous guanine nucleotides but does not interfere with the association of GDP to p21. These results suggest that the nucleotide ex
Publikováno v:
Molecular and Cellular Biology. 7:3092-3097
Point mutations of p21 proteins were constructed by oligonucleotide-directed mutagenesis of the v-rasH oncogene, which substituted amino acid residues within the nucleotide-binding consensus sequence, GXG GXGK. When the glycine residue at position 10
EndoR . NgoII, a class II restriction endonuclease isolated from Neisseria gonorrhoeae, was purified to electrophoretic homogeneity. We were able to separate it from another restriction endonuclease of N. gonorrhoeae, NgoI, by phosphocellulose chroma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eb1df096b1cf41f660e438c6b8e0e90
https://europepmc.org/articles/PMC218313/
https://europepmc.org/articles/PMC218313/